Sign in

CIK 0000879407

  • Large accelerated filer

ARROWHEAD PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
460408024
Phone
+1 626-696-4702
Business address
177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
Former names
ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
  1. 4 Open-market sale Chief Executive Officer sold 164,834 shares at $14.45 ($2,381,851)
  2. 4 Open-market sale Chief Financial Officer sold 20,000 shares at $14.01 ($280,200)
  3. 4 Open-market sale Chief Financial Officer sold 14,000 shares at $11.00 ($154,000)
  4. 4 Open-market sale Director sold 25,000 shares at $6.63 ($165,750)
  5. 4 Open-market sale Chief Financial Officer sold 20,000 shares at $8.00 ($160,000)
  6. 4 Open-market sale Chief Executive Officer sold 26,000 shares at $7.40 ($192,400)
  7. 4 Open-market sale Chief Executive Officer sold 300,000 shares at an average $7.43 ($2,228,000)
  8. 4 Open-market sale Chief Operating Officer sold 20,000 shares at $6.73 ($134,600)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 8,208 shares (to pay taxes)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Director acquired 25,000 shares (grant or award)
  12. 4 Grant or award Director acquired 25,000 shares (grant or award)
  13. 4 Grant or award Director acquired 30,000 shares (grant or award)
  14. 4 Grant or award Director acquired 30,000 shares (grant or award)
  15. 4 Grant or award VP, Strategic Bus. Initiatives acquired 40,000 shares (grant or award)
  16. 4 Grant or award General Counsel acquired 60,000 shares (grant or award)
  17. 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
  18. 4 Open-market sale Chief Operating Officer sold 20,000 shares at $3.69 ($73,800)
  19. 4 Grant or award Chief Executive Officer acquired 500,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 14 of 25 · 497 filings